Publications: Research Papers


Negotiating Health and Autonomy: Data Exclusivity, Healthcare Policies and Access to Pharmaceutical Innovations
Research Paper 204, 24 July 2024

By Henrique Zeferino De Menezes, Julia Paranhos, Ricardo Lobato Torres, Luciana Correia Borges, Daniela De Santana Falcão and Gustavo Soares Felix Lima

What Can Cambodia Learn from Thailand and India as It Prepares to Graduate from Least Developed Country Status?
Research Paper 198, 31 May 2024

By Brigitte Tenni, Deborah Gleeson, Joel Lexchin, Phin Sovath, and Chalermsak Kittitrakul
Licencias obligatorias para exportación: operacionalización en el orden jurídico argentino
Documento de Investigación 196, 19 de abril de 2024

Por Valentina Delich
Régimen de licencias obligatorias y uso público no comercial en Argentina
Documento de Investigación 195, 6 de marzo de 2024

Por Juan Ignacio Correa
Desafíos actuales y posibles escenarios futuros de la salud mundial
Documento de Investigación 193, 2 de Febrero de 2024

By Germán Velásquez
Pautas para el examen de patentes sobre anticuerpos monoclonales
Documento de Investigación 192, 30 de enero de 2024

Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
Implementing the Doha Declaration in OAPI Legislation: Do Transition Periods Matter?
Research Paper 190, 24 January 2024

By Patrick Juvet Lowé Gnintedem
Patentamiento de anticuerpos monoclonales. El caso de Argentina
Documento de Investigación 186, 14 de noviembre de 2023

Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini

Promoting Jordan’s Use of Compulsory Licensing During the Pandemic
Research Paper 184, 15 September 2023

By Laila Barqawi
Where Does Global Health Funding Come From and Where Does It Go?
Research Paper 176, 29 March 2023

By Germán Velásquez

De dónde viene y a dónde va el financiamiento para la salud mundial
Documento de Investigación 176, 29 de marzo de 2023

Por Germán Velásquez
Experiencias internacionales sobre la concesión de licencias obligatorias por razones de salud pública
Documento de Investigación 175, 22 de marzo de 2023

Por Catalina de la Puente, Gastón Palopoli, Constanza Silvestrini, Juan Correa
Analysis of COVID-Related Patents for Antibodies and Vaccines
Research Paper 173, 7 February 2023

By Kausalya Santhanam
Directives pour l’examen des demandes de brevet relatives aux produits pharmaceutiques
Document de Recherche No. 171, 31 janvier 2023

Par Carlos M Correa
Pautas para el Examen de Solicitudes de Patentes Relacionadas con Productos Farmacéuticos
Documento De Investigación 171, 29 De Noviembre De 2022

Por Carlos M Correa
The WTO TRIPS Decision on COVID-19 Vaccines: What is Needed to Implement it?
Research Paper 169, 8 November 2022

By Carlos M. Correa and Nirmalya Syam
Manufacturing for Export: A TRIPS-Consistent Pro-Competitive Exception
Research Paper 155, 27 May 2022

by Carlos M. Correa and Juan I. Correa
COVID-19 Vaccines as Global Public Goods: between life and profit
Research Paper 154, 9 May 2022

By Katiuska King Mantilla and César Carranza Barona
An Examination of Selected Public Health Exceptions in Asian Patent Laws
Research Paper 152, 21 April 2022

By Kiyoshi Adachi
The Right to Health in Pharmaceutical Patent Disputes
Research Paper 145, 9 February 2022

Emmanuel Kolawole Oke
Competition Law and Access to Medicines: Lessons from Brazilian Regulation and Practice
Research Paper 142, 4 January 2022

Matheus Z. Falcão, Mariana Gondo and Ana Carolina Navarrete

Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
Documento de investigación 140, Noviembre 2021

Germán Velásquez
Canada’s Political Choices Restrain Vaccine Equity: The Bolivia-Biolyse Case
Research Paper 136, September 2021

Muhammad Zaheer Abbas, PhD
Restructuring the Global Vaccine Industry
Research Paper 134, September 2021

Felix Lobo
Repensando la fabricación mundial y local de productos médicos tras el COVID-19
Documento de investigación 118, Junio 2021

Germán Velásquez
Interpreting the Flexibilities Under the TRIPS Agreement
Research Paper 132, June 2021

Carlos M. Correa
Les réformes de l’Organisation mondiale de la Santé a l’époque de COVID-19
Document de Recherche 121, Janvier 2021

Germán Velásquez
Designing Pro-Health Competition
Policies in Developing Countries

Research Paper 125, December 2020

Vitor Henrique Pinto Ido
Las reformas de la Organización Mundial de la Salud en la época de COVID-19
Documento de investigación 121, Noviembre 2020

Germán Velásquez
The World Health Organization Reforms in the Time of COVID-19
Research Paper 121, November 2020

Germán Velásquez
Re-thinking Global and Local Manufacturing of Medical Products After COVID-19
Research Paper 118, September 2020

Dr. Germán Velásquez
Equitable Access to COVID-19 Related Health Technologies: A Global Priority
Research Paper 114, June 2020

Dr. Zeleke Temesgen Boru
Eighteen Years After Doha: An Analysis of the Use of Public Health TRIPS Flexibilities in Africa
Research Paper 103, February 2020

Yousuf A Vawda and Bonginkosi Shozi

Second Medical Use Patents – Legal Treatment and Public Health Issues
Research Paper 101, December 2019

Clara Ducimetière
Medicines and Intellectual Property: 10 Years of the WHO Global Strategy
Research Paper 100, December 2019

Dr. Germán Velásquez
The International Debate on Generic Medicines of Biological Origin
Research Paper 82, November 2017

Germán Velásquez
Hepatitis C Treatment: A Global Problem
Research Paper 77, May 2017

Germán Velásquez
The Bolar Exception: Legislative Models and Drafting Options
Research Paper 66, March 2016

Carlos M. Correa
Guidelines on Patentability and Access to Medicines
Research Paper 61, March 2015

Germán Velásquez